The assessment of functional status in individual's who have cancer;Kanserli bireylerin fonksiyonel durumlarinin deǧerlendirilmesi

Turkiye Klinikleri Journal of Medical Sciences

Volumn 26, Issue 5, 2006, Pages 488-499

  Aydin Bektaş, Hicran ^a   Akdemir, Nuran ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Neoplasms; Quality of life

Indexed keywords

ANAMNESIS; ARTICLE; BREAST CANCER; CANCER RESEARCH; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FUNCTIONAL STATUS; HUMAN; INFORMATION PROCESSING; INTERVIEW; LUNG CANCER; MAJOR CLINICAL STUDY;

EID: 33751223524     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bilir N. Bulaşici olmayan hastaliklarin kontrolü ve yaşlilik sorunlari. Bertan M, Güler Ç, editörler. Halk Saǧliǧi Temel Bilgiler. 2. Baski. Ankara: Güneş Kitabevi; 1997. s.359-68.
2. Seffrin JR. An end-game for cancer. CA Cancer J Clin 2000;50:4-5.
3. Akdemir N, Birol L. Kanser tedavileri ve hemşirelik bakimi. İç Hastaliklari ve Hemşirelik Bakimi. 1. Baski. İstanbul: Vehbi Koç Vakfi. Sanerc Yayinlari; 2003. s.243-306.
4. Kutluk T, Kars A. Dünyada-Türkiyede kanser. Kanser Konusunda Genel Bilgiler. 7. Baski. Ankara: T.C. Saǧlik Bakanliǧi Kanser ve Savaş Daire Başkanliǧi, Türk Kanser Arastirma ve Savaş Kurumu Yayinlari; 1996. s.39-46.
5. Greenlee R, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
6. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
7. Firat D, Çelik İ. Cancer Statistics in Turkey and in the World 1993-1995 Turkish Association For the Cancer Research and Control, Ankara: 1998. p.30-3.
8. Baird S. (Ed.) A Cancer Source Book for Nurses. (Çev. Ed. N. Platin) Hemşireler İçin Kanser El Kitabi. AÇEM ve 4. 2. Baski. Ankara: Akşam Sanat Okulu Matbaasi; 1998. s.175-85.
9. Akyol AD. Yaşam kalitesinin hemşirelik yönünden önemi. Ege Üniversitesi HYO Dergisi 1993;9:71-5.
10. Ganz PA. Quality of life and the patient with cancer. Individual and policy implications. Cancer 1994;74(4 Suppl):1445-52.
11. Eski S, Fesci H. Miyokart enfarktüsti geçiren bireylerin yaşam kalitelerinin belirlenmesi. HEMAR-G Dergisi 2002;4:15-28.
12. Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Qual Life Res 1999;8:447-59.
13. Wensing M, Vingerhoets E, Grol R. Functional status, health problems, age and comorbidity in primary care patients. Qual Life Res 2001;10:141-8.
14. Leidy NK. Functional status and the forward progress of merry-go-rounds: Toward a coherent analytical framework. Nurs Res 1994;43:196-202.
15. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59-65.
16. Cella DF, Tulsky DS. Measuring quality of life today: Methodological aspects. Oncology 1990;4:29-38.
17. Costantini M, Mencaglia E, Giulio PD, et al. Cancer patients as "experts" in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO). Qual Life Res 2000;9:151-9.
18. Erdem E, Çavuşoǧlu H. Kanserli çocuklarin ebeveynlerinin yaşam kalitesi. Hacettepe Universitesi HYO Dergisi 1999;6:1-10.
19. th ed. Canada: Jones and Bartlett Publishers; 2000. p.243-59.
20. Beck LA. Cancer rehabilitation: Does it make a difference? Rehabil Nurs (Glenview) 2003;28:42-7.
21. Sümbülog̈lu K, Sümbüloǧlu V. Önemlilik testleri. Biyoistatistik. 8. Baski. Ankara: Hatipoǧlu Yayinevi; 1998. s.76-156.
22. Akgül A. Araştirmanin planlanmasi. Tibbi Araş tirmalarda İstatistiksel Analiz Teknikleri. "SPSS Uygulamalari". 2. Baski. Ankara: Yeni Mustafa Kitabevi; 2003. s.41-56.
23. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. J Clin Oncol 1984;2:472-83.
24. nd ed. Philadelphia: Lippincott-Raven; 1996. p.215-25.
25. Montazeri A, Harirchi I, Vahdani M, et al. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): Translation and validation study of the Iranian version. Qual Life Res 2000;9:177-84.
26. Özdamar K. Güvenirlik ve soru analizi. Paket Programlar ile İstatistiksel Veri Analizi. 4. Baski. Eskişehir: Kaan Kitabevi; 2002. s.661-76.
27. Ulusoy MF, Uçar H. Onam formu. Araştirma Etiǧi. 1. Baski. Ankara: 72 Tasarim Ltd. Şti; 2002. s.109-11.
28. Winer E, Gold D, Lees J, et al. Quality of life (QL) following high dose chemotherapy with autologous bone marrow support (HDC) in patients with metastatic breast cancer. Proc Annu Meet Am Soc Clin Oncol 1991;9(A):122-9.
29. Winer EP, Lindley C, Hardee M, et al. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psychooncology 1999;8:167-76.
30. Lheureux M, Raherison C, Vernejoux JM, et al. Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer 2004;43:175-82.
31. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: A systematic review of the medical literature. Palliat Med 2000;14:363-74.
32. Addington-Hall J, Kalra L. Measuring quality of life: Who should measure quality of life? BMJ 2001;322:1417-20.
33. Ko CY, Maggard M, Livingston EH. Evaluating health utility in patients with melanoma, breast cancer, colon cancer and lung cancer: A nationwide, population-based assessment. J Surg Res 2003;114:1-5.
34. Ringdal GI, Ringdal K. A follow-up study of the quality of life in cancer patients with different prognoses. Qual Life Res 2000;9:65-73.
35. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Qual Life Res 2002;11:207-21.
36. Ruckdeschel JC, Piantadosi S. Quality of life in lung cancer surgical adjuvant trials. Chest 1994;106(6 Suppl):324-8.
37. Holzner B, Kemmler G, Koop M, et al. Quality of life in breast cancer patients-not enough attention for long-term survivors? Psychosomatics 2001;42:117-23.
38. Kieren DK, Nabholtz JM, Makar K, Cumming CE. Sexuality, body image and quality of life after high dose or conventional chemotherapy for metastatic breast cancer. Can J Hum Sex 1997;6:1-8.
39. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-14.
40. Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998;16:1380-7.
41. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-6.
42. Ferrell BR. The impact of pain on quality of life: A decade of research. Nurs Clin North Am 1995;30:609-24.
43. Owen JE, Klapow JC, Casebeer L. Evaluating the relationship between pain presantation and health-related quality of life in outpatients with metastatic or recurrent neoplastic disease. Qual Life Res 2000;9:855-63.
44. Spiegel D, Sands S, Koopman C. Pain anddepression in patients with cancer. Cancer 1994;74:2570-8.
45. Rummans TA, Frost M, Suman VJ, et al. Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics 1998;39:437-45.
46. Dibble SL, Isreal J, Nussey B, Casey K, Luce J. Delayed chemotherapy-induced nausea in women treated for breast cancer. Oncol Nurs Forum 2003;30:E40-7.
47. Schnell FM. Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control. Oncologist 2003;8:187-98.